Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Ewa Orlewska; Ioan Ancuta; Branimir Anic; Catalin Codrenau; Nemanja Damjanov; Predrag Djukic; Ruxandra Ionescu; Lubomir Marinchev; Evgeny L. Nasonov; Tonu Peets; Sonja Praprotnik; Rasho Rashkov; Jana Skoupa; Witold Tlustochowicz; Malgorzata Tlustochowicz; Matija Tomsic; Tiina Veldi; Jelena Vojinovic; Piotr Wiland

doi:10.12659/MSM.881697

01 April 2011

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Ewa Orlewska^ABCDEFG, Ioan Ancuta^B, Branimir Anic^B, Catalin Codrenau^B, Nemanja Damjanov^B, Predrag Djukic^B, Ruxandra Ionescu^B, Lubomir Marinchev^B, Evgeny L. Nasonov^B, Tonu Peets^B, Sonja Praprotnik^B, Rasho Rashkov^B, Jana Skoupa^B, Witold Tlustochowicz^B, Malgorzata Tlustochowicz^B, Matija Tomsic^B, Tiina Veldi^B, Jelena Vojinovic^B, Piotr Wiland^B

DOI: 10.12659/MSM.881697

Med Sci Monit 2011; 17(4): SR1-13

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Back to the Article

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries

Your Privacy